Core Viewpoint - The company plans to use up to 90 million yuan of idle raised funds to temporarily supplement its working capital, ensuring that the funds will be returned to the dedicated account within 12 months [1][6][8]. Fundraising Overview - The company raised a total of 1,075,950,160 yuan from its initial public offering (IPO) by issuing 51,333,500 shares at a price of 20.96 yuan per share, with a net amount of 978,927,778.72 yuan after deducting issuance costs [2][5]. - Additionally, the company raised 203,920,127.60 yuan through a share issuance for asset acquisition, issuing 13,032,886 shares at a price of 16.42 yuan per share, after deducting related costs [3][5]. Use of Funds - The funds from the IPO are allocated to projects related to the company's main business, with a total investment amount of 622 million yuan planned for various projects [5]. - The funds raised for asset acquisition are intended for cash compensation, intermediary fees, and taxes related to the transaction, totaling 214 million yuan [5]. Temporary Use of Idle Funds - The company intends to use up to 90 million yuan of idle funds, including 87 million yuan from the IPO and 3 million yuan from the asset acquisition, to support its production and operations [6][7]. - The use of these funds will not affect the normal progress of the fundraising projects and will comply with relevant regulations [6][8]. Approval Process - The board of directors approved the proposal to use idle funds on August 22, 2025, and this decision does not require shareholder approval [7][8]. - The independent financial advisor and sponsor have provided a no-objection opinion regarding this matter, confirming compliance with regulatory requirements [8].
三友医疗: 关于使用部分闲置募集资金暂时补充流动资金的公告